Preliminary studies show conolidine may inhibit unique ion channels, lowering neuronal excitability and limiting agony signals. This system is particularly pertinent in neuropathic soreness, in which abnormal signaling will cause persistent soreness. On top of that, conolidine appears to influence G protein-coupled receptor (GPCR) pathways integral to discomfort perception. https://heinzx850rhw5.myparisblog.com/profile